1. Home
  2. EMR vs SNY Comparison

EMR vs SNY Comparison

Compare EMR & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Emerson Electric Company

EMR

Emerson Electric Company

N/A

Current Price

$162.17

Market Cap

82.8B

Sector

Technology

ML Signal

N/A

Logo Sanofi ADS

SNY

Sanofi ADS

N/A

Current Price

$46.88

Market Cap

95.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EMR
SNY
Founded
1890
1994
Country
United States
France
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.8B
95.7B
IPO Year
1994
2001

Fundamental Metrics

Financial Performance
Metric
EMR
SNY
Price
$162.17
$46.88
Analyst Decision
Buy
Buy
Analyst Count
30
11
Target Price
★ $174.82
$53.48
AVG Volume (30 Days)
2.5M
★ 4.4M
Earning Date
11-04-2026
10-30-2026
Dividend Yield
1.46%
★ 5.16%
EPS Growth
★ 17.78
N/A
EPS
★ 3.45
N/A
Revenue
★ $24,412,000,000.00
N/A
Revenue This Year
$5.14
$3.80
Revenue Next Year
$5.50
$5.20
P/E Ratio
$49.40
★ $6.14
Revenue Growth
★ 0.78
N/A
52 Week Low
$122.64
$39.07
52 Week High
$172.00
$52.68

Technical Indicators

Market Signals
Indicator
EMR
SNY
Relative Strength Index (RSI) 49.40 71.76
Support Level $154.30 $45.95
Resistance Level $165.58 $48.78
Average True Range (ATR) 5.39 0.86
MACD -0.39 0.67
Stochastic Oscillator 44.05 85.04

Price Performance

Historical Comparison
EMR
SNY

About EMR Emerson Electric Company

Founded in 1890 as the first manufacturer of electric fans in North America, Emerson Electric has become a leading industrial automation player through the acquisition of established brands. Emerson organizes its business into seven segments that sell a wide range of automation software, power tools, and automation hardware such as valves, gauges, and switches. In recent years, Emerson divested its climate technology and consumer businesses to become more of a pure-play industrial automation company. The automation of a factory is an enticing long-term proposition for manufacturers, helping reduce accident rates and raise uptime and productivity.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest-revenue product, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: